Catalyst Wire Dossier Catalyst Wire Dossier

Capmatinib

capmatinib · Novartis
Drug timelines are a Plus or Pro feature.

18 regulatory and trial events tracked for Capmatinib, covering 2018-07-26 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC. [Phase 4]

See pricing